Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are seeing a doctor because they have been newly diagnosed with, or have had a return of, Multiple Myeloma (a type of blood cancer), based on internationally recognised diagnostic standards
- People who have agreed to take part in the study and to have biological samples (such as blood or tissue) collected as part of it
- People who are covered by a social security or health insurance scheme
Who may not be able to join:
- People under 18 years of age
- Adults who are under legal guardianship or a court-appointed protective arrangement
- People who fall under other legal protection measures (confirm with trial site)
- Women who are pregnant or currently breastfeeding
- People receiving a specific type of state medical assistance known as AME (confirm with trial site for details on what this covers)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Cyrille TOUZEAU, PU, Nantes University Hospital
Phone: 02 40 08 32 71
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Describe the mechanisms of resistance of myeloma cells.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.